4//SEC Filing
Weinhoff Gregory M 4
Accession 0001847903-25-000013
CIK 0001847903other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:32 PM ET
Size
5.6 KB
Accession
0001847903-25-000013
Insider Transaction Report
Form 4
Weinhoff Gregory M
Chief Business Officer
Transactions
- Sale
Ordinary Shares
2025-01-27$16.47/sh−11,742$193,429→ 159,782 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 22, 2024.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.22 to $16.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001400975
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:32 PM ET
- Size
- 5.6 KB